In a Trader’s Dairy segment, Zee Business Senior Research Analyst Varun Dubey and Research Analyst Ashish Chaturvedi suggest to buy stocks on the basis of cash, F&O, and news impact for bumper returns.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

In this regard, Dubey suggests to buy RailTel shares in cash for a target of Rs 148 apiece with a stop loss of 139 per share and suggests to Sell JSW Steel shares in Futures for a target of Rs 650 per share and stop loss of Rs 680 apiece.

See Zee Business Live TV Streaming Below:

The senior research analyst recommends to buy Apollo Hospital 3750 CE shares in Option for a target of Rs 143 per share with a stop loss of 110 per share.

Similarly, on technical terms, he picks Star Paper and on fundamental terms HDFC Bank for a target price of Rs 158 and Rs 1540 per share with a stop loss of Rs149 and Rs 1450 per share respectively.

With respect to investment, Dubey suggests to invest in Advanced Enzymes for a target of Rs 500 per share in three months, and Panacea Biotec shares will have a news impact, as DGCI approves manufacturing license for Sputnik V, he sets Rs 395 apiece target and stop loss of Rs 370 per share.

In the My Choice section, Dubey chooses, Redington for a target of Rs 307 per share and stop loss of Rs 287 per share, while Cupid and IB Real Estate as an intraday call for a target of Rs 250 and Rs 117 per share with a stop loss of Rs 235 and Rs 110 per share respectively.

Similarly, Chaturvedi suggests to buy Dalmia Bharat shares in cash for a target of Rs 2180 per share and stop loss of Rs 1900 apiece. 

The research analyst picks ICICI Bank Futures shares for Rs 660 per share returns with support at Rs 630 apiece and mentions Reliance Inds 2140 CE Options shares to grow by Rs 62 apiece with a stop loss of Rs 47 per share.

On technical terms, Chaturvedi suggests Zen Tech shares to buy for a target of Rs 112 per share and stop loss of 93 apiece, while on fundamental terms he expects Blue Dart shares would give returns or Rs 6170 per share with a stop loss of Rs 5835 per share.

With an investment view, Chaturvedi suggests to buy Delta Corp shares for a target of Rs 300 with a timeline of 18 months. He says, Indian Hume Pipes shares would grow to Rs 244 per share with stop loss of Rs 223 apiece. The company gets a letter of acceptance for an order of Rs 257 crore.

In the My Choice section, the research analyst chooses Strides Pharma for a target of Rs 820 per share and stop loss of Rs 770 per share, while IRCTC and Nalco as a short-term investment for a target of Rs 2180 and Rs 2033 per share with a stop loss of Rs 91 and Rs 75 per share respectively.